- Healthy children previously immunized with 1 or 2 doses of Prevenar.
- Group 1: Male or female subjects between the age of >=140 and time of enrollment.
- Group 2: Male or female subjects between the age of >=336 and time of enrollment
- Available for entire study period.
- Previous reaction or contra-indication to pneumococcal vaccine or vaccine related
- Previous vaccination with licensed or investigational pneumococcal vaccine other than